Health Care and Corporate Finance
Health care costs for U.S. employers have tripled in the past twenty years. By constructing a novel dataset with firm-specific health care expenses, I show that firms negatively adjust both capital expenditures and R&D expenses in response to changes in health care costs. I estimate that, on average, a 1% increase in health care costs is associated with a 0.7% decrease in total investment. The effects are stronger for financially constrained firms, firms employing more high-skilled workers, and firms working with fewer insurers. Additional tests confirm that hiring fewer workers and reducing wages do not offset rising health costs enough to counteract this lower investment channel. Overall, my findings suggest that rising health care costs limit firms’ ability to expand either physically or via innovation.

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Rights for Collection: Duke Dissertations
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info